USPTO Examiner HIRT ERIN E - Art Unit 1617

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18793091Herbicidal compositions comprising trifludimoxazinAugust 2024September 2024Allow200YesNo
18433701METHOD FOR CONTROLLING THE GROWTH OF UNDESIRABLE VEGETATIONFebruary 2024March 2025Abandon1301NoNo
18393184PROTOPORPHYRINOGEN OXIDASE INHIBITORSDecember 2023January 2025Allow1310NoNo
18334724MOLECULE HAVING PESTICIDAL UTILITY, AND COMPOSITIONS, AND PROCESSES, RELATED THERETOJune 2023December 2024Allow1810YesNo
18091476PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOFDecember 2022April 2025Allow2820YesNo
17941323COMPOSITIONS AND METHODS FOR INHIBITION AND INTERRUPTION OF BIOFILM FORMATIONSeptember 2022January 2025Abandon2830NoNo
17802298HERBICIDAL MALONAMIDESAugust 2022March 2025Allow3000YesNo
17769523A DISPERSIBLE EXTENDED RELEASE COMPOSITION, AND A PROCESS FOR PREPARING THE SAMEApril 2022April 2025Abandon3610NoNo
17542126Composition for a Plant Growth AdditiveDecember 2021March 2025Abandon3910NoNo
17517760SOLID HERBICIDE COMPOSITION AND THE USE THEREOFNovember 2021February 2025Abandon3910NoNo
17484980Combination of Novel Nitrification Inhibitors and Herbicides as Well as Combination of (Thio)Phosphoric Acid Triamides and HerbicidesSeptember 2021February 2025Allow4140YesNo
17429516HERBICIDAL COMPOUNDSAugust 2021December 2024Allow4010YesNo
17309843JASMONIC ACID ENDOGENY PROMOTING AGENT, AND METHOD FOR PROMOTING JASMONIC ACID ENDOGENYJune 2021March 2025Abandon4510NoNo
17291257COMPOSITIONS COMPRISING PYRIDINE CARBOXYLATE HERBICIDES AND ACETYL COA CARBOXYLASE (ACCASE) INHIBITOR HERBICIDESMay 2021October 2024Abandon4210NoNo
17289763COMPOSITIONS COMPRISING PYRIDINE CARBOXYLATE HERBICIDES WITH PDS INHIBITOR HERBICIDESApril 2021October 2024Abandon4210NoNo
17239434MICROALGAE BASED COMPOSITIONS AND METHODS FOR APPLICATION TO PLANTSApril 2021November 2024Abandon4320NoNo
17287250MICROCAPSULE COMPOSITION, METHOD FOR MANUFACTURING SAME, AGROCHEMICAL FORMULATION COMPRISING SAME AND WEED CONTROL METHODApril 2021February 2025Allow4640YesNo
17285687PHENYLPYRAZOLE COMPOUND AND METHOD FOR CONTROLLING PLANT DISEASEApril 2021September 2024Allow4210NoNo
17283293PESTICIDAL COMPOUNDSApril 2021May 2025Allow4911YesNo
17261602HERBICIDAL MIXTURES COMPRISING ISOXAFLUTOLE, TRIFLUDIMOXAZIN AND AN IMIDAZOLINONE HERBICIDE; AND THEIR USE IN SOYBEAN AND COTTON CULTURESJanuary 2021May 2025Abandon5231YesNo
17054846PEST CONTROL COMPOSITIONS AND USES THEREOFNovember 2020June 2025Abandon5541NoNo
17065085Formulations Containing Paraffinic Oil and Anti-Settling AgentOctober 2020April 2025Allow5440YesNo
16963995HERBICIDALLY ACTIVE 3-PHENYLISOXAZOLINE-5-CARBOXAMIDES OF CYCLOPENTENYLCARBOXYLIC ACID DERIVATIVESJuly 2020March 2025Allow5640YesNo
16962398PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTSJuly 2020June 2025Allow5921YesYes
16763004HERBICIDAL PYRIDYLETHERSMay 2020February 2025Allow5731YesNo
16633482USE OF HERBICIDAL COMPOSITIONS BASED ON L-GLUFOSINATE IN TOLERANT FIELD CROPSJanuary 2020February 2025Abandon6051NoNo
16493875PLANT DISEASE CONTROL AGENTSeptember 2019July 2024Allow5850YesNo
16491461THREE-DIMENSIONAL INSECT REPELLING SHEET FOR CONTROLLING GRAIN-STORAGE INSECT PESTSSeptember 2019April 2025Abandon6060NoNo
15779949Pyridine Compounds as FungicidesMay 2018February 2020Allow2111YesNo
15749659AGRICULTURAL ADJUVANT COMPOSITIONS AND METHODS FOR USING SUCH COMPOSITIONSFebruary 2018January 2021Abandon3661YesNo
15885710Synergistic Agricultural Formula Comprising Diacyl or Diaryl Urea and At Least One Mixture of NutrientsJanuary 2018May 2025Allow6070YesYes
15662436COMPOSITION WITH INSECT REPELLENT ACTIVITYJuly 2017February 2019Allow1820YesNo
15544272PESTICIDALLY ACTIVE SEMI-CARBAZONES AND THIOSEMICARBAZONES DERIVATIVESJuly 2017March 2020Allow3221YesNo
15535347SUBSTITUTED 6-ANILINO-9-HETEROCYCLYLPURINE DERIVATIVES FOR INHIBITION OF PLANT STRESSJune 2017March 2020Allow3331YesNo
15534158AQUEOUS DISPERSION OF A PESTICIDE AND POLYMER PARTICLES CONTAINING A COPOLYMERIZABLE SURFACTANTJune 2017September 2024Allow6071YesNo
15518833PESTICIDALLY ACTIVE TETRACYCLIC HETEROCYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTSApril 2017June 2019Allow2631YesYes
15309183PYRAZOLOPYRIDINE SULFONAMIDES AS NEMATICIDESNovember 2016April 2018Allow1711YesNo
15341118MATERIALS WITH IMPROVED BIOCPMPATIBILITYNovember 2016August 2024Allow6091YesYes
15105062Thioamides and Amides for Controlling Animal PestsJune 2016March 2019Allow3321YesNo
14895343Substituted 5-Hydroxy-2,3-Diphenylpentanonitrile Derivatives, Processes For Their Preparation And Their Use As Herbicides And/Or Plant Growth RegulatorsDecember 2015March 2018Allow2721YesNo
14930790PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETONovember 2015December 2016Allow1321YesNo
14880739PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETOOctober 2015March 2017Allow1721YesNo
14880696PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETOOctober 2015December 2016Allow1421YesNo
14880651PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETOOctober 2015August 2016Allow1021NoNo
14880782PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETOOctober 2015August 2016Allow1031NoNo
14880357PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETOOctober 2015December 2016Allow1421YesNo
14880790PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETOOctober 2015December 2016Allow1421YesNo
14880766PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETOOctober 2015December 2016Allow1421YesNo
14857507METHOD OF PREPARING AMIDOAMINE ALKOXYLATES AND COMPOSITIONS THEREOFSeptember 2015March 2018Allow30120NoNo
14437859DIHYDROPYRONE COMPOUNDS AND HERBICIDES COMPRISING THE SAMEApril 2015June 2017Allow2520NoYes
14433722PYRONE COMPOUNDS AND HERBICIDES COMPRISING THE SAMEApril 2015October 2017Allow3111NoNo
14421086NANOPARTICLE COMPOSITIONS OF ANTIBACTERIAL COMPOUNDS AND OTHER USES THEREOFFebruary 2015January 2017Allow2310YesNo
14371620Herbicidal Isoxazolo[5,4-B]PyridinesJuly 2014May 2017Allow3421YesNo
14259229PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETOApril 2014April 2015Allow1110YesNo
14133034PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETODecember 2013July 2015Allow1910YesNo
14132931PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETODecember 2013July 2015Allow1910YesNo
14133094PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETODecember 2013August 2015Allow2010YesNo
14132853PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETODecember 2013August 2015Allow1910YesNo
14132947PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETODecember 2013August 2015Allow1910NoNo
14132977PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETODecember 2013July 2015Allow1910YesNo
14132871PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETODecember 2013July 2015Allow1910YesNo
14124033AZOLE DERIVATIVE, METHOD FOR PRODUCING AZOLE DERIVATIVE, AND INTERMEDIATE COMPOUNDDecember 2013November 2015Allow2310NoNo
14122944TRIAZOLE COMPOUND AND USE THEREOFNovember 2013October 2015Allow2311YesNo
14088926INHIBITION OF BIOFILMS IN PLANTS WITH IMIDAZOLE DERIVATIVESNovember 2013September 2014Allow920YesNo
14117159CYCLOHEXANONE COMPOUNDS AND HERBICIDES COMPRISING THE SAMENovember 2013April 2015Allow1701YesNo
14111271Use of substituted dithiine-dicarboximides for combating phytopathogenic fungiOctober 2013May 2015Allow1901YesNo
14111270Use of substituted dithiine-tetracarboximides for combating phytopathogenic fungiOctober 2013October 2015Allow2411NoNo
14047056ANTIMICROBIAL AND ANTIFOULING CATECHOL-CONTAINING POLYCARBONATES FOR MEDICAL APPLICATIONSOctober 2013September 2018Allow5931NoYes
14009601Substituted pyrimidinium compounds for combating animal pestsOctober 2013May 2015Allow2001YesNo
13979546PARTICLE COMPOSITION AND PHARMACEUTICAL COMPOSITION USING PARTICLE COMPOSITIONSeptember 2013January 2016Allow3011YesNo
13261726AUXIN BIOSYNTHESIS INHIBITORAugust 2013October 2015Allow2511NoNo
13970456Dynamic Macropore Formation Using Multiple PorogensAugust 2013July 2016Allow3520YesYes
13887758TRANSDERMAL DELIVERY SYSTEMMay 2013March 2015Allow2220YesNo
13768264Guerbet Alcohol Mixtures and Uses ThereofFebruary 2013January 2016Allow3520YesNo
13714556Combined used of Lipo-Chitooligosaccharides and Chitinous Compounds for Enhanced Plant Growth and YieldDecember 2012September 2015Allow3350YesNo
13606723PESTICIDAL COMPOSITIONSSeptember 2012March 2013Allow600NoNo
13449826COMPOSITIONS AND METHODS FOR NUTRITIONAL SUPPLEMENTATIONApril 2012June 2015Allow3830YesNo
13368384PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETOFebruary 2012January 2014Allow2301YesNo
13333136Hemostatic Materials and Devices with Galvanic ParticulatesDecember 2011January 2015Allow3720YesYes
13140436COMBINED DISINFECTION AND DECONTAMINATION AGENT HAVING INCREASED EFFECTIVENESSAugust 2011December 2014Allow4220YesYes
13135247In-situ forming hydrogel wound dressings containing antimicrobial agentsJune 2011September 2015Allow5021YesYes
13134926PHARMACEUTICAL COMPOSITIONS COMPRISING WATER-SOLUBLE SULFONATE-PROTECTED NANOPARTICLES AND USES THEREOFJune 2011February 2014Allow3220NoNo
13063411ABSORPTION OF THERAPEUTIC AGENTS ACROSS MUCOSAL MEMBRANES OR THE SKINMarch 2011March 2014Allow3641YesNo
13058168CRYSTALLINE ACTIVE INGREDIENT MICROPARTICLES, METHOD FOR PRODUCING THE SAME AND USE THEREOF IN DRUGSFebruary 2011July 2015Allow5430YesNo
13000860MEDICAL SUPPLIES AND METHOD OF PRODUCING THE SAMEDecember 2010January 2025Abandon60121YesYes
12665706PARTICULATES OF A CRTH2 ANTAGONISTNovember 2010April 2013Allow4011NoNo
12866948CLEANING, SANITISING AND STERILISING PREPARATIONSAugust 2010May 2015Allow5750YesYes
12720146POWDER-FREE ANTIMICROBIAL COATED GLOVEMarch 2010July 2015Allow6050YesNo
12698566PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATIONFebruary 2010June 2015Allow6040YesNo
12514441HERBICIDE COMBINATIONS WITH PARTICULAR SULPHONYL UREASSeptember 2009September 2014Allow6040YesYes
12516226COMPACT FOR INSECT CONTROLMay 2009October 2017Allow6090NoYes
12515569Agrochemical Formulations Comprising Co-polymers Based on DiisocyanatesMay 2009May 2015Allow6060NoNo
12386716Delivery of hydrophobic benefit agents from bodywashes and the like onto a keratinous substrateApril 2009October 2012Abandon4180YesNo
12293923PRODUCTION AND USE OF ENDOPHYTES AS NOVEL INOCULANTS FOR PROMOTING ENHANCED PLANT VIGOR, HEALTH, GROWTH, YIELD REDUCING ENVIRONMENTAL STRESS AND FOR REDUCING DEPENDENCY ON CHEMICAL PESTICIDES FOR PEST CONTROLSeptember 2008November 2011Allow3800YesNo
12210621PESTICIDAL COMPOSITIONSSeptember 2008June 2012Allow4520YesNo
11914526INSECTICIDAL SUBSTITUTED BENZYLAMINO HETEROCYCLIC AND HETEROARYL DERIVATIVESSeptember 2008April 2012Allow5321NoNo
11572400SELECTIVE INSECTICIDES BASED ON SUBSTITUTED CYCLIC KETOENOLS AND SAFENERSJuly 2008January 2012Allow6020YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HIRT, ERIN E.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
5
Examiner Affirmed
3
(60.0%)
Examiner Reversed
2
(40.0%)
Reversal Percentile
60.0%
Higher than average

What This Means

With a 40.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
16
Allowed After Appeal Filing
8
(50.0%)
Not Allowed After Appeal Filing
8
(50.0%)
Filing Benefit Percentile
75.6%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner HIRT, ERIN E - Prosecution Strategy Guide

Executive Summary

Examiner HIRT, ERIN E works in Art Unit 1617 and has examined 95 patent applications in our dataset. With an allowance rate of 84.2%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 34 months.

Allowance Patterns

Examiner HIRT, ERIN E's allowance rate of 84.2% places them in the 54% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by HIRT, ERIN E receive 2.62 office actions before reaching final disposition. This places the examiner in the 88% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by HIRT, ERIN E is 34 months. This places the examiner in the 22% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +31.9% benefit to allowance rate for applications examined by HIRT, ERIN E. This interview benefit is in the 83% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 15.7% of applications are subsequently allowed. This success rate is in the 6% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 48.0% of cases where such amendments are filed. This entry rate is in the 67% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 100.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 68% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 73.7% of appeals filed. This is in the 58% percentile among all examiners. Of these withdrawals, 57.1% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 82.4% are granted (fully or in part). This grant rate is in the 93% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 0% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 5.0% of allowed cases (in the 79% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Expect multiple rounds of prosecution: This examiner issues more office actions than average. Address potential issues proactively in your initial response and consider requesting an interview early in prosecution.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.